ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase 3 Papulopustular Rosacea Study

ClinicalTrials.gov ID: NCT01494467

Public ClinicalTrials.gov record NCT01494467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double Blind, 12 Week Vehicle Controlled, Parallel Group Study Assessing the Efficacy and Safety of CD5024 1 % Cream Versus Vehicle Cream in Subjects With Papulopustular Rosacea, Followed by a 40 Week Investigator Blinded Extension Comparing the Long Term Safety of CD5024 1% Cream Versus Azelaic Acid 15 % Gel.

Study identification

NCT ID
NCT01494467
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Galderma R&D
Industry
Enrollment
688 participants

Conditions and interventions

Interventions

  • Azelaic acid 15% Gel Drug
  • CD5024 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
Jul 31, 2013
Completion
Jul 31, 2013
Last update posted
Feb 17, 2021

2011 – 2013

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
Total Skin and Beauty Birmingham Alabama 35205
Coastal Clinical Research, Inc. Mobile Alabama 36608
Burke Pharmaceutical Research Hot Springs Arkansas 71913
Dermatology Specialists, Inc Oceanside California 92056
Integrated Research Group, Inc Riverside California 92506
Therapeutics Clinical Research San Diego California 92123
University of California, San Francisco San Francisco California 94143
ATS Clinical Research Santa Monica California 90404
Redwood Dermatology Research Santa Rosa California 95403
FXM Research Corp Miami Miami Florida 33175
Leavitt Medical Associates of Florida dba Ameriderm Research Ormond Beach Florida
Atlanta Dermatology, Vein & Research Center, LLC Alpharetta Georgia 30022
Emory University Atlanta Georgia 30322
Altman Dermatology Associates Arlington Heights Illinois 60005
Northwestern University Chicago Illinois 60611
Deaconess Clinic, Inc. Evansville Indiana 47713
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
Dermatology Specialists Research Louisville Kentucky 40202
Northeast Dermatology Associates Beverly Massachusetts 01915
David Fivenson, MD, PLC Ann Arbor Michigan 48103
Hamzavi Dermatology Fort Gratiot Michigan 48059
Somerset Skin Centre Troy Michigan 48084
Dermatology Clinical Trials Unit St Louis Missouri 63141
Psoriasis Treatment Center of NJ West Windsor New Jersey
Academic Dermatology Associates Albuquerque New Mexico 87106
DermResearch Center of New York, Inc Stony Brook New York 11790
Not listed High Point North Carolina 27262
PMG Research of Raleigh, LLC Raleigh North Carolina 27609
Oregon Dermatology and Research Center Portland Oregon 97210
Dermatology and Skin Surgery Center Exton Pennsylvania 19341
Philadelphia Institute of Dermatology Fort Washington Pennsylvania 19034
Penn State Hershey Medical Center Hershey Pennsylvania 17033
Paddington Research Philadelphia Pennsylvania 19103
Yardley Dermatology Associates Yardley Pennsylvania 19067
The Skin Wellness Center Knoxville Tennessee 37922
Dermatology Reserach Associates Nashville Tennessee 17203
Arlington Research Center, Inc Arlington Texas 76011
Stephen Miller MD San Antonio Texas 78229
Not listed San Antonio Texas 78229
Center for Clinical Studies Webster Texas 77598

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01494467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01494467 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →